SELL TO SCIENTISTS.

Biotech

Illumina

Illumina dominates the DNA sequencing market with approximately 80% market share. Its sequencing platforms have driven the cost of genome sequencing down by orders of magnitude, enabling the genomics revolution in research and clinical diagnostics.

$1.1B R&D Spend
Biotech Industry
580 Academic Collaborations
4,200 Patents

Industry

Biotech →

Free to browse · subscribe to unlock the full dataset

See the full dataset.

Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.

Sign Up Free →
Get Started